Matrixyl (palmitoyl pentapeptide)
Matrixyl (palmitoyl pentapeptide)
Jumlah
Pesanan minimum adalah: 200 boxsPengiriman
Pemasok akan mengirim dalam 3–15 hari setelah pembayaran dikonfirmasi.
Barang akan dikirim dari United Kingdom, China pelabuhan.
Pengiriman ditawarkan dengan syarat FOB — pemasok menanggung biaya ke pelabuhan pengiriman yang ditentukan.
Pembayaran: Western Union
Sampel tersedia · $380.00/per sampel
Euromart Suppliers perlindungan pesanan
Setiap pembayaran Anda diamankan dengan enkripsi SSL ketat dan protokol perlindungan data PCI DSS
Lakukan pengembalian lokal gratis untuk produk cacat pada pembelian yang memenuhi syarat
Klaim pengembalian dana jika pesanan tidak dikirim, hilang, atau tiba dengan masalah produk
Meet your supplier
Distributor / Wholesaler • 3 yr • 
UNITED KINGDOM
56%
On-time delivery rate
≤24h
Response Time
75
Employee Size
$500K
Annual Revenue
588
Products Sold
Location
Belfast, United Kingdom
Matrixyl (Palmitoyl Pentapeptide‑4) is a trademarked cosmetic peptide developed by Sederma/Croda, designed to stimulate collagen and elastin synthesis, reduce wrinkles, and improve skin firmness. It is available in several commercial configurations such as Matrixyl®, Matrixyl® 3000, Matrixyl® Synthe’6, and Matrixyl® Morphomics®.
KEY FEATURES
Collagen stimulation: Boosts synthesis of collagen types I, III, and IV by up to 350% in vitro.
Fibronectin & elastin: Increases production by up to 200%, improving elasticity.
Wrinkle reduction: Clinical studies show visible decreases in wrinkle depth and fine lines.
Skin repair: Supports wound healing and dermal regeneration.
Non‑irritating: Gentler than retinoids, compatible with other actives.
TECHNICAL SPECIFICATIONS
INCI Name (original Matrixyl): Palmitoyl Pentapeptide‑4 (Pal‑KTTKS).
Sequence: Lys‑Thr‑Thr‑Lys‑Ser (KTTKS) with palmitoyl fatty acid chain for enhanced penetration.
Molecular Weight: ~805 Da
Form: Cosmetic grade peptide, ≥95% purity, typically supplied as powder or solution
Solubility: Water‑soluble when formulated with carriers.
Recommended Concentration: 3–5% in topical formulations (serums, creams, lotions)
Application Protocol: Twice daily; results visible after 4–8 weeks
Storage: 4–7 °C, stable for 24 months (Matrixyl 3000)
AVALAIBLE CONFIGURATION
Matrixyl® (original) — Palmitoyl Pentapeptide‑4. This was the first generation peptide, proven to stimulate collagen types I, III, and IV, reduce wrinkles, and improve skin firmness.
Matrixyl® 3000 — A blend of Palmitoyl Tripeptide‑1 and Palmitoyl Tetrapeptide‑7. It enhances collagen and elastin production while also reducing inflammation, making it one of the most widely used versions in serums.
Matrixyl® Synthe’6 — Palmitoyl Tripeptide‑38. This variant targets dermal matrix repair, filling deeper wrinkles and stimulating multiple structural proteins including collagen, fibronectin, and hyaluronic acid.
Matrixyl® Morphomics® — A newer proprietary peptide complex. It focuses on sagging and facial contours, marketed as a solution for “morphological” signs of aging.
Matrixyl® Inside — A branding initiative used by skincare companies to certify that their products contain genuine Croda Matrixyl peptides.
GB
